Feldan's proprietary Shuttle peptide technology enables the efficient and targeted delivery of biomolecules into cells, unlocking new therapeutic possibilities
Genomics is transforming the future of modern medicine and treatment modalities across specialties
The plant will have installed production capacity of 3,120 MT/month
Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
Women Health Card was launched exclusively for women health workers of the Tiruchirappalli City Corporation
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
Subscribe To Our Newsletter & Stay Updated
